Loading…
Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection
Introduction: The only definite way to determine lymph node metastasis, an unfavorable prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and the increasing trend towards minimally invasive surgery, ways to avoid or at least limit lymphadenectomy are being sought. We...
Saved in:
| Published in: | European urology 2002-08, Vol.42 (2), p.84-92 |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3 |
| container_end_page | 92 |
| container_issue | 2 |
| container_start_page | 84 |
| container_title | European urology |
| container_volume | 42 |
| creator | Burkhard, Fiona C Bader, Pia Schneider, Eric Markwalder, Regula Studer, Urs E |
| description | Introduction:
The only definite way to determine lymph node metastasis, an unfavorable prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and the increasing trend towards minimally invasive surgery, ways to avoid or at least limit lymphadenectomy are being sought. We routinely performed a meticulous lymphadenectomy in all patients and the goal of this study was to evaluate which of the previously proposed criteria determining who needs a lymphadenectomy can be applied in our patients.
Patients and Methods:
Patients with clinically localized prostate cancer confirmed by fine needle aspiration cytology, without neoadjuvant hormone therapy, negative pelvic and abdominal CT scans and negative bone scan underwent a radical prostatectomy with simultaneous bilateral extended lymphadenectomy.
Results:
Between 1989 and 1999, 463 patients were included in this study. The median age was 64 (range 44–76) years and the median PSA was 11.0 (range 0.42–172) ng/ml. A median of 21 nodes were removed per patient. One hundred and nine (24%) had lymph node metastasis: 17% of patients with a PSA value ≤20
ng/ml and 12% with a PSA value ≤10
ng/ml. None of the patients with a preoperative grading of 1 and a PSA value ≤10
ng/ml and 10% of the “low-risk patients” with a PSA value ≤10
ng/ml and a preoperative grading |
| doi_str_mv | 10.1016/S0302-2838(02)00243-9 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71979274</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283802002439</els_id><sourcerecordid>71979274</sourcerecordid><originalsourceid>FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3</originalsourceid><addsrcrecordid>eNqFkc1uFDEQhC0EIpvAI4D6hOAw4J-d8fiE0IYA0hIi_q6Wx25rjWbGG9sbtK_BE-NkV3DMqS9fVXdXEfKM0deMsu7NNyoob3gv-peUv6KUL0WjHpAF66VoZNvRh2TxDzkhpzn_opSKVonH5IRx1tFWygX58xXHYIYwhrKH6OEqYdxiMiXcIPw04w4zlAjnWDBNYUYoG4RLRAc-Jljvp-3GOJzRljjtIcxwVaU4lwy_Q9lUu5iLKQgrM1tMYGYHn7EEuxvjLh_0cBkdwnnIubqEOD8hj7wZMz49zjPy4-L999XHZv3lw6fVu3VjheKlae3AW89Ey9TQ1YeZN465ThrGl8i5ob5jPeeu9wNS74eBWyGlwUF4pbx04oy8OPhuU7yufxY9hWxxHM2M9TgtmZKKy-W9IKe0E13PKtgeQFvfzgm93qYwmbTXjOrb1vRda_q2El3nXWtaVd3z44LdMKH7rzrWVIG3BwBrHjcBk862pmzRhVRD0y6Ge1b8BS7xqaU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20063681</pqid></control><display><type>article</type><title>Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection</title><source>ScienceDirect Freedom Collection</source><creator>Burkhard, Fiona C ; Bader, Pia ; Schneider, Eric ; Markwalder, Regula ; Studer, Urs E</creator><creatorcontrib>Burkhard, Fiona C ; Bader, Pia ; Schneider, Eric ; Markwalder, Regula ; Studer, Urs E</creatorcontrib><description>Introduction:
The only definite way to determine lymph node metastasis, an unfavorable prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and the increasing trend towards minimally invasive surgery, ways to avoid or at least limit lymphadenectomy are being sought. We routinely performed a meticulous lymphadenectomy in all patients and the goal of this study was to evaluate which of the previously proposed criteria determining who needs a lymphadenectomy can be applied in our patients.
Patients and Methods:
Patients with clinically localized prostate cancer confirmed by fine needle aspiration cytology, without neoadjuvant hormone therapy, negative pelvic and abdominal CT scans and negative bone scan underwent a radical prostatectomy with simultaneous bilateral extended lymphadenectomy.
Results:
Between 1989 and 1999, 463 patients were included in this study. The median age was 64 (range 44–76) years and the median PSA was 11.0 (range 0.42–172) ng/ml. A median of 21 nodes were removed per patient. One hundred and nine (24%) had lymph node metastasis: 17% of patients with a PSA value ≤20
ng/ml and 12% with a PSA value ≤10
ng/ml. None of the patients with a preoperative grading of 1 and a PSA value ≤10
ng/ml and 10% of the “low-risk patients” with a PSA value ≤10
ng/ml and a preoperative grading <3 had lymph node metastases. Seven percent with a PSA value ≤10
ng/ml and a prostatectomy Gleason score under 7 were found to be node positive.
Conclusions:
A significant number of patients would have been understaged and left with diseased nodes when applying preoperative PSA value ≤10
ng/ml and grading <3/Gleason <7 as criteria for omitting lymphadenectomy. Therefore we consider meticulous lymphadenectomy a must for correct staging in all patients undergoing radical prostatectomy for prostate cancer, with the exception of patients with a grading of 1 and a PSA ≤10
ng/ml.</description><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/S0302-2838(02)00243-9</identifier><identifier>PMID: 12160577</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Adult ; Aged ; Gleason score ; Grading ; Humans ; Lymph Node Excision ; Lymph node metastasis ; Lymphadenectomy ; Lymphatic Metastasis - diagnosis ; Male ; Middle Aged ; Predictive Value of Tests ; Preoperative Care ; Prognosis ; Prostate cancer ; Prostate-Specific Antigen - blood ; Prostatectomy ; Prostatic Neoplasms - pathology ; Prostatic Neoplasms - surgery ; PSA</subject><ispartof>European urology, 2002-08, Vol.42 (2), p.84-92</ispartof><rights>2002 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3</citedby><cites>FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27898,27899</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12160577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burkhard, Fiona C</creatorcontrib><creatorcontrib>Bader, Pia</creatorcontrib><creatorcontrib>Schneider, Eric</creatorcontrib><creatorcontrib>Markwalder, Regula</creatorcontrib><creatorcontrib>Studer, Urs E</creatorcontrib><title>Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection</title><title>European urology</title><addtitle>Eur Urol</addtitle><description>Introduction:
The only definite way to determine lymph node metastasis, an unfavorable prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and the increasing trend towards minimally invasive surgery, ways to avoid or at least limit lymphadenectomy are being sought. We routinely performed a meticulous lymphadenectomy in all patients and the goal of this study was to evaluate which of the previously proposed criteria determining who needs a lymphadenectomy can be applied in our patients.
Patients and Methods:
Patients with clinically localized prostate cancer confirmed by fine needle aspiration cytology, without neoadjuvant hormone therapy, negative pelvic and abdominal CT scans and negative bone scan underwent a radical prostatectomy with simultaneous bilateral extended lymphadenectomy.
Results:
Between 1989 and 1999, 463 patients were included in this study. The median age was 64 (range 44–76) years and the median PSA was 11.0 (range 0.42–172) ng/ml. A median of 21 nodes were removed per patient. One hundred and nine (24%) had lymph node metastasis: 17% of patients with a PSA value ≤20
ng/ml and 12% with a PSA value ≤10
ng/ml. None of the patients with a preoperative grading of 1 and a PSA value ≤10
ng/ml and 10% of the “low-risk patients” with a PSA value ≤10
ng/ml and a preoperative grading <3 had lymph node metastases. Seven percent with a PSA value ≤10
ng/ml and a prostatectomy Gleason score under 7 were found to be node positive.
Conclusions:
A significant number of patients would have been understaged and left with diseased nodes when applying preoperative PSA value ≤10
ng/ml and grading <3/Gleason <7 as criteria for omitting lymphadenectomy. Therefore we consider meticulous lymphadenectomy a must for correct staging in all patients undergoing radical prostatectomy for prostate cancer, with the exception of patients with a grading of 1 and a PSA ≤10
ng/ml.</description><subject>Adult</subject><subject>Aged</subject><subject>Gleason score</subject><subject>Grading</subject><subject>Humans</subject><subject>Lymph Node Excision</subject><subject>Lymph node metastasis</subject><subject>Lymphadenectomy</subject><subject>Lymphatic Metastasis - diagnosis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Predictive Value of Tests</subject><subject>Preoperative Care</subject><subject>Prognosis</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatectomy</subject><subject>Prostatic Neoplasms - pathology</subject><subject>Prostatic Neoplasms - surgery</subject><subject>PSA</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNqFkc1uFDEQhC0EIpvAI4D6hOAw4J-d8fiE0IYA0hIi_q6Wx25rjWbGG9sbtK_BE-NkV3DMqS9fVXdXEfKM0deMsu7NNyoob3gv-peUv6KUL0WjHpAF66VoZNvRh2TxDzkhpzn_opSKVonH5IRx1tFWygX58xXHYIYwhrKH6OEqYdxiMiXcIPw04w4zlAjnWDBNYUYoG4RLRAc-Jljvp-3GOJzRljjtIcxwVaU4lwy_Q9lUu5iLKQgrM1tMYGYHn7EEuxvjLh_0cBkdwnnIubqEOD8hj7wZMz49zjPy4-L999XHZv3lw6fVu3VjheKlae3AW89Ey9TQ1YeZN465ThrGl8i5ob5jPeeu9wNS74eBWyGlwUF4pbx04oy8OPhuU7yufxY9hWxxHM2M9TgtmZKKy-W9IKe0E13PKtgeQFvfzgm93qYwmbTXjOrb1vRda_q2El3nXWtaVd3z44LdMKH7rzrWVIG3BwBrHjcBk862pmzRhVRD0y6Ge1b8BS7xqaU</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Burkhard, Fiona C</creator><creator>Bader, Pia</creator><creator>Schneider, Eric</creator><creator>Markwalder, Regula</creator><creator>Studer, Urs E</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20020801</creationdate><title>Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection</title><author>Burkhard, Fiona C ; Bader, Pia ; Schneider, Eric ; Markwalder, Regula ; Studer, Urs E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Gleason score</topic><topic>Grading</topic><topic>Humans</topic><topic>Lymph Node Excision</topic><topic>Lymph node metastasis</topic><topic>Lymphadenectomy</topic><topic>Lymphatic Metastasis - diagnosis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Predictive Value of Tests</topic><topic>Preoperative Care</topic><topic>Prognosis</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatectomy</topic><topic>Prostatic Neoplasms - pathology</topic><topic>Prostatic Neoplasms - surgery</topic><topic>PSA</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burkhard, Fiona C</creatorcontrib><creatorcontrib>Bader, Pia</creatorcontrib><creatorcontrib>Schneider, Eric</creatorcontrib><creatorcontrib>Markwalder, Regula</creatorcontrib><creatorcontrib>Studer, Urs E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burkhard, Fiona C</au><au>Bader, Pia</au><au>Schneider, Eric</au><au>Markwalder, Regula</au><au>Studer, Urs E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>42</volume><issue>2</issue><spage>84</spage><epage>92</epage><pages>84-92</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><abstract>Introduction:
The only definite way to determine lymph node metastasis, an unfavorable prognostic factor in prostate cancer is lymphadenectomy. Due to increased morbidity and the increasing trend towards minimally invasive surgery, ways to avoid or at least limit lymphadenectomy are being sought. We routinely performed a meticulous lymphadenectomy in all patients and the goal of this study was to evaluate which of the previously proposed criteria determining who needs a lymphadenectomy can be applied in our patients.
Patients and Methods:
Patients with clinically localized prostate cancer confirmed by fine needle aspiration cytology, without neoadjuvant hormone therapy, negative pelvic and abdominal CT scans and negative bone scan underwent a radical prostatectomy with simultaneous bilateral extended lymphadenectomy.
Results:
Between 1989 and 1999, 463 patients were included in this study. The median age was 64 (range 44–76) years and the median PSA was 11.0 (range 0.42–172) ng/ml. A median of 21 nodes were removed per patient. One hundred and nine (24%) had lymph node metastasis: 17% of patients with a PSA value ≤20
ng/ml and 12% with a PSA value ≤10
ng/ml. None of the patients with a preoperative grading of 1 and a PSA value ≤10
ng/ml and 10% of the “low-risk patients” with a PSA value ≤10
ng/ml and a preoperative grading <3 had lymph node metastases. Seven percent with a PSA value ≤10
ng/ml and a prostatectomy Gleason score under 7 were found to be node positive.
Conclusions:
A significant number of patients would have been understaged and left with diseased nodes when applying preoperative PSA value ≤10
ng/ml and grading <3/Gleason <7 as criteria for omitting lymphadenectomy. Therefore we consider meticulous lymphadenectomy a must for correct staging in all patients undergoing radical prostatectomy for prostate cancer, with the exception of patients with a grading of 1 and a PSA ≤10
ng/ml.</abstract><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>12160577</pmid><doi>10.1016/S0302-2838(02)00243-9</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0302-2838 |
| ispartof | European urology, 2002-08, Vol.42 (2), p.84-92 |
| issn | 0302-2838 1873-7560 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_71979274 |
| source | ScienceDirect Freedom Collection |
| subjects | Adult Aged Gleason score Grading Humans Lymph Node Excision Lymph node metastasis Lymphadenectomy Lymphatic Metastasis - diagnosis Male Middle Aged Predictive Value of Tests Preoperative Care Prognosis Prostate cancer Prostate-Specific Antigen - blood Prostatectomy Prostatic Neoplasms - pathology Prostatic Neoplasms - surgery PSA |
| title | Reliability of Preoperative Values to Determine the Need for Lymphadenectomy in Patients with Prostate Cancer and Meticulous Lymph Node Dissection |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-26T16%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reliability%20of%20Preoperative%20Values%20to%20Determine%20the%20Need%20for%20Lymphadenectomy%20in%20Patients%20with%20Prostate%20Cancer%20and%20Meticulous%20Lymph%20Node%20Dissection&rft.jtitle=European%20urology&rft.au=Burkhard,%20Fiona%20C&rft.date=2002-08-01&rft.volume=42&rft.issue=2&rft.spage=84&rft.epage=92&rft.pages=84-92&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/S0302-2838(02)00243-9&rft_dat=%3Cproquest_cross%3E71979274%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c392t-5cb25f13519b67561fad1d67a124e22a0f61822d8fbe0ffbb2c377aeb3f99f7d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20063681&rft_id=info:pmid/12160577&rfr_iscdi=true |